APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pulmonary Disease Aerosol Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pulmonary Disease Aerosol Delivery Devices Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchPulmonary Disease Aerosol Delivery Devices Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pulmonary Disease Aerosol Delivery Devices Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Pulmonary Disease Aerosol Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pulmonary Disease Aerosol Delivery Devices Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Pulmonary Disease Aerosol Delivery Devices Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pulmonary Disease Aerosol Delivery Devices market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pulmonary Disease Aerosol Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pulmonary Disease Aerosol Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pulmonary Disease Aerosol Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pulmonary Disease Aerosol Delivery Devices is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pulmonary Disease Aerosol Delivery Devices include Novartis, Merck, Viatris, GlaxoSmithKline (GSK), AstraZeneca, Vectura, Teva Pharmaceutical Industries, PARI International and OMRON, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pulmonary Disease Aerosol Delivery Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pulmonary Disease Aerosol Delivery Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Pulmonary Disease Aerosol Delivery Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pulmonary Disease Aerosol Delivery Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pulmonary Disease Aerosol Delivery Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pulmonary Disease Aerosol Delivery Devices sales, projected growth trends, production technology, application and end-user industry.

Pulmonary Disease Aerosol Delivery Devices Segment by Company

Novartis

Merck

Viatris

GlaxoSmithKline (GSK)

AstraZeneca

Vectura

Teva Pharmaceutical Industries

PARI International

OMRON

Monaghan Medical

Koninklijke Philips

H&T Presspart

Chiesi Farmaceutici

Boehringer Ingelheim

AptarGroup

Pulmonary Disease Aerosol Delivery Devices Segment by Type

Metered- dose Inhalers

Dry-powder Inhalers

Nebulizers

Pulmonary Disease Aerosol Delivery Devices Segment by Application

Asthma

Idiopathic Pulmonary Fibrosis (IPF)

Cystic Fibrosis (CF)

Chronic Obstructive Pulmonary Disease (COPD)

Others

Pulmonary Disease Aerosol Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pulmonary Disease Aerosol Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pulmonary Disease Aerosol Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pulmonary Disease Aerosol Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pulmonary Disease Aerosol Delivery Devices in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pulmonary Disease Aerosol Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pulmonary Disease Aerosol Delivery Devices sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Metered- dose Inhalers Major Manufacturers Table 3. Dry-powder Inhalers Major Manufacturers Table 4. Nebulizers Major Manufacturers Table 5. Global Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Asthma Major Manufacturers Table 7. Idiopathic Pulmonary Fibrosis (IPF) Major Manufacturers Table 8. Cystic Fibrosis (CF) Major Manufacturers Table 9. Chronic Obstructive Pulmonary Disease (COPD) Major Manufacturers Table 10. Others Major Manufacturers Table 11. Pulmonary Disease Aerosol Delivery Devices Industry Trends Table 12. Pulmonary Disease Aerosol Delivery Devices Industry Drivers Table 13. Pulmonary Disease Aerosol Delivery Devices Industry Opportunities and Challenges Table 14. Pulmonary Disease Aerosol Delivery Devices Industry Restraints Table 15. Global Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region (2021-2026) Table 19. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region (2027-2032) Table 20. Global Pulmonary Disease Aerosol Delivery Devices Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2021-2026) & (K Units) Table 22. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2027-2032) & (K Units) Table 23. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Region (2021-2026) Table 24. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Region (2027-2032) Table 25. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Pulmonary Disease Aerosol Delivery Devices Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Manufacturers (2021-2026) Table 29. Global Pulmonary Disease Aerosol Delivery Devices Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Pulmonary Disease Aerosol Delivery Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Pulmonary Disease Aerosol Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Pulmonary Disease Aerosol Delivery Devices Manufacturers, Product Type & Application Table 33. Global Pulmonary Disease Aerosol Delivery Devices Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Pulmonary Disease Aerosol Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Type (2021-2026) Table 40. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Type (2027-2032) Table 41. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 43. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (K Units) Table 44. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Type (2021-2026) Table 45. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Type (2027-2032) Table 46. Global Pulmonary Disease Aerosol Delivery Devices Price by Type (2021-2026) & (US$/Unit) Table 47. Global Pulmonary Disease Aerosol Delivery Devices Price by Type (2027-2032) & (US$/Unit) Table 48. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Application (2021-2026) Table 52. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Application (2027-2032) Table 53. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 55. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (K Units) Table 56. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Application (2021-2026) Table 57. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Application (2027-2032) Table 58. Global Pulmonary Disease Aerosol Delivery Devices Price by Application (2021-2026) & (US$/Unit) Table 59. Global Pulmonary Disease Aerosol Delivery Devices Price by Application (2027-2032) & (US$/Unit) Table 60. Novartis Company Information Table 61. Novartis Business Overview Table 62. Novartis Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Novartis Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 64. Novartis Recent Development Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Merck Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 69. Merck Recent Development Table 70. Viatris Company Information Table 71. Viatris Business Overview Table 72. Viatris Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Viatris Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 74. Viatris Recent Development Table 75. GlaxoSmithKline (GSK) Company Information Table 76. GlaxoSmithKline (GSK) Business Overview Table 77. GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 79. GlaxoSmithKline (GSK) Recent Development Table 80. AstraZeneca Company Information Table 81. AstraZeneca Business Overview Table 82. AstraZeneca Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. AstraZeneca Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 84. AstraZeneca Recent Development Table 85. Vectura Company Information Table 86. Vectura Business Overview Table 87. Vectura Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Vectura Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 89. Vectura Recent Development Table 90. Teva Pharmaceutical Industries Company Information Table 91. Teva Pharmaceutical Industries Business Overview Table 92. Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 94. Teva Pharmaceutical Industries Recent Development Table 95. PARI International Company Information Table 96. PARI International Business Overview Table 97. PARI International Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. PARI International Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 99. PARI International Recent Development Table 100. OMRON Company Information Table 101. OMRON Business Overview Table 102. OMRON Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. OMRON Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 104. OMRON Recent Development Table 105. Monaghan Medical Company Information Table 106. Monaghan Medical Business Overview Table 107. Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 109. Monaghan Medical Recent Development Table 110. Koninklijke Philips Company Information Table 111. Koninklijke Philips Business Overview Table 112. Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 114. Koninklijke Philips Recent Development Table 115. H&T Presspart Company Information Table 116. H&T Presspart Business Overview Table 117. H&T Presspart Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. H&T Presspart Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 119. H&T Presspart Recent Development Table 120. Chiesi Farmaceutici Company Information Table 121. Chiesi Farmaceutici Business Overview Table 122. Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 124. Chiesi Farmaceutici Recent Development Table 125. Boehringer Ingelheim Company Information Table 126. Boehringer Ingelheim Business Overview Table 127. Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 129. Boehringer Ingelheim Recent Development Table 130. AptarGroup Company Information Table 131. AptarGroup Business Overview Table 132. AptarGroup Pulmonary Disease Aerosol Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. AptarGroup Pulmonary Disease Aerosol Delivery Devices Product Portfolio Table 134. AptarGroup Recent Development Table 135. North America Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 138. North America Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (K Units) Table 139. North America Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 140. North America Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 141. North America Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 144. North America Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (K Units) Table 145. North America Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 146. North America Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 147. North America Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 152. North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2027-2032) & (K Units) Table 153. North America Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 154. North America Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 155. United States Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 156. Canada Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 157. Mexico Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 158. Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 161. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (K Units) Table 162. Europe Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Europe Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 167. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (K Units) Table 168. Europe Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Europe Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Europe Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 175. Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (2027-2032) & (K Units) Table 176. Europe Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Europe Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Germany Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 179. France Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 180. U.K. Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 181. Italy Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 182. Russia Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 183. Spain Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 185. Switzerland Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 186. Sweden Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 187. Poland Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 188. China Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 189. China Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 190. China Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 191. China Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (K Units) Table 192. China Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 193. China Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 194. China Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 195. China Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 196. China Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 197. China Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (K Units) Table 198. China Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 199. China Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 201. Asia Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 202. Asia Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 203. Asia Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (K Units) Table 204. Asia Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 205. Asia Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 206. Asia Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 207. Asia Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 209. Asia Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (K Units) Table 210. Asia Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 211. Asia Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Asia Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Asia Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Asia Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. Asia Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 217. Asia Pulmonary Disease Aerosol Delivery Devices Sales by Country (2027-2032) & (K Units) Table 218. Asia Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 219. Asia Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Japan Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 221. South Korea Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 222. India Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 223. Australia Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 224. Taiwan Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 225. Southeast Asia Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 226. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 227. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 228. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2026) & (K Units) Table 229. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Type (2027-2032) & (K Units) Table 230. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2021-2026) & (US$/Unit) Table 231. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales Price by Type (2027-2032) & (US$/Unit) Table 232. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 233. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 234. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2026) & (K Units) Table 235. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Application (2027-2032) & (K Units) Table 236. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2021-2026) & (US$/Unit) Table 237. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales Price by Application (2027-2032) & (US$/Unit) Table 238. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 242. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021-2026) & (K Units) Table 243. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Country (2027-2032) & (K Units) Table 244. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2021-2026) & (US$/Unit) Table 245. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales Price by Country (2027-2032) & (US$/Unit) Table 246. Brazil Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 247. Argentina Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 248. Chile Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 249. Colombia Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 250. Peru Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 251. Saudi Arabia Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 252. Israel Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 253. UAE Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 254. Turkey Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 255. Iran Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 256. Egypt Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Pulmonary Disease Aerosol Delivery Devices Distributors List Table 260. Pulmonary Disease Aerosol Delivery Devices Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Pulmonary Disease Aerosol Delivery Devices Image Figure 2. Global Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pulmonary Disease Aerosol Delivery Devices Market Size Share 2021 VS 2025 VS 2032 Figure 4. Metered- dose Inhalers Image Figure 5. Dry-powder Inhalers Image Figure 6. Nebulizers Image Figure 7. Global Pulmonary Disease Aerosol Delivery Devices Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pulmonary Disease Aerosol Delivery Devices Market Size Share 2021 VS 2025 VS 2032 Figure 9. Asthma Image Figure 10. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 11. Cystic Fibrosis (CF) Image Figure 12. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 13. Others Image Figure 14. Global Pulmonary Disease Aerosol Delivery Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Pulmonary Disease Aerosol Delivery Devices Revenue (2021-2032) & (US$ Million) Figure 16. Global Pulmonary Disease Aerosol Delivery Devices Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region (2021-2032) Figure 19. Global Pulmonary Disease Aerosol Delivery Devices Sales (2021-2032) & (K Units) Figure 20. Global Pulmonary Disease Aerosol Delivery Devices Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Pulmonary Disease Aerosol Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 23. Europe Pulmonary Disease Aerosol Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 24. China Pulmonary Disease Aerosol Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Pulmonary Disease Aerosol Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Pulmonary Disease Aerosol Delivery Devices Sales YoY (2021-2032) & (K Units) Figure 27. Global Pulmonary Disease Aerosol Delivery Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Pulmonary Disease Aerosol Delivery Devices Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Type (2021-2032) Figure 33. Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Type (2021-2032) Figure 36. Global Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Application (2021-2032) Figure 39. Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Application (2021-2032) Figure 42. North America Pulmonary Disease Aerosol Delivery Devices Revenue Share by Type (2021-2032) Figure 43. North America Pulmonary Disease Aerosol Delivery Devices Sales Share by Type (2021-2032) Figure 44. North America Pulmonary Disease Aerosol Delivery Devices Revenue Share by Application (2021-2032) Figure 45. North America Pulmonary Disease Aerosol Delivery Devices Sales Share by Application (2021-2032) Figure 46. North America Pulmonary Disease Aerosol Delivery Devices Revenue Share by Country (2021-2032) Figure 47. North America Pulmonary Disease Aerosol Delivery Devices Sales Share by Country (2021-2032) Figure 48. Europe Pulmonary Disease Aerosol Delivery Devices Revenue Share by Type (2021-2032) Figure 49. Europe Pulmonary Disease Aerosol Delivery Devices Sales Share by Type (2021-2032) Figure 50. Europe Pulmonary Disease Aerosol Delivery Devices Revenue Share by Application (2021-2032) Figure 51. Europe Pulmonary Disease Aerosol Delivery Devices Sales Share by Application (2021-2032) Figure 52. Europe Pulmonary Disease Aerosol Delivery Devices Revenue Share by Country (2021-2032) Figure 53. Europe Pulmonary Disease Aerosol Delivery Devices Sales Share by Country (2021-2032) Figure 54. China Pulmonary Disease Aerosol Delivery Devices Revenue Share by Type (2021-2032) Figure 55. China Pulmonary Disease Aerosol Delivery Devices Sales Share by Type (2021-2032) Figure 56. China Pulmonary Disease Aerosol Delivery Devices Revenue Share by Application (2021-2032) Figure 57. China Pulmonary Disease Aerosol Delivery Devices Sales Share by Application (2021-2032) Figure 58. Asia Pulmonary Disease Aerosol Delivery Devices Revenue Share by Type (2021-2032) Figure 59. Asia Pulmonary Disease Aerosol Delivery Devices Sales Share by Type (2021-2032) Figure 60. Asia Pulmonary Disease Aerosol Delivery Devices Revenue Share by Application (2021-2032) Figure 61. Asia Pulmonary Disease Aerosol Delivery Devices Sales Share by Application (2021-2032) Figure 62. Asia Pulmonary Disease Aerosol Delivery Devices Revenue Share by Country (2021-2032) Figure 63. Asia Pulmonary Disease Aerosol Delivery Devices Sales Share by Country (2021-2032) Figure 64. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue Share by Type (2021-2032) Figure 65. SAMEA Pulmonary Disease Aerosol Delivery Devices Sales Share by Type (2021-2032) Figure 66. SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue Share by Application (2021-2032) Figure 67. SAMEA Pulmonary Disease Aerosol Delive

Scope & coverage.

Types
  • Metered- dose Inhalers
  • Dry-powder Inhalers
  • Nebulizers
Applications
  • Asthma
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Cystic Fibrosis (CF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Others
Companies covered
  • Novartis
  • Merck
  • Viatris
  • GlaxoSmithKline (GSK)
  • AstraZeneca
  • Vectura
  • Teva Pharmaceutical Industries
  • PARI International
  • OMRON
  • Monaghan Medical
  • Koninklijke Philips
  • H&T Presspart
  • Chiesi Farmaceutici
  • Boehringer Ingelheim
  • AptarGroup

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pulmonary Disease Aerosol Delivery Devices Market by Type
  3. 1.2.1 Global Pulmonary Disease Aerosol Delivery Devices Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Metered- dose Inhalers
  5. 1.2.3 Dry-powder Inhalers
  6. 1.2.4 Nebulizers
  7. 1.3 Pulmonary Disease Aerosol Delivery Devices Market by Application
  8. 1.3.1 Global Pulmonary Disease Aerosol Delivery Devices Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Asthma
  10. 1.3.3 Idiopathic Pulmonary Fibrosis (IPF)
  11. 1.3.4 Cystic Fibrosis (CF)
  12. 1.3.5 Chronic Obstructive Pulmonary Disease (COPD)
  13. 1.3.6 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Pulmonary Disease Aerosol Delivery Devices Market Dynamics
  1. 2.1 Pulmonary Disease Aerosol Delivery Devices Industry Trends
  2. 2.2 Pulmonary Disease Aerosol Delivery Devices Industry Drivers
  3. 2.3 Pulmonary Disease Aerosol Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Pulmonary Disease Aerosol Delivery Devices Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region
  3. 3.2.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region (2021-2026)
  5. 3.2.3 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Region (2027-2032)
  6. 3.2.4 Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pulmonary Disease Aerosol Delivery Devices Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pulmonary Disease Aerosol Delivery Devices Sales by Region
  9. 3.4.1 Global Pulmonary Disease Aerosol Delivery Devices Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2021-2026)
  11. 3.4.3 Global Pulmonary Disease Aerosol Delivery Devices Sales by Region (2027-2032)
  12. 3.4.4 Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Manufacturers
  2. 4.1.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pulmonary Disease Aerosol Delivery Devices Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pulmonary Disease Aerosol Delivery Devices Sales by Manufacturers
  6. 4.2.1 Global Pulmonary Disease Aerosol Delivery Devices Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pulmonary Disease Aerosol Delivery Devices Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pulmonary Disease Aerosol Delivery Devices Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pulmonary Disease Aerosol Delivery Devices Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pulmonary Disease Aerosol Delivery Devices Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pulmonary Disease Aerosol Delivery Devices Manufacturers, Product Type & Application
  13. 4.7 Global Pulmonary Disease Aerosol Delivery Devices Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pulmonary Disease Aerosol Delivery Devices Market CR5 and HHI
  16. 4.8.2 2025 Pulmonary Disease Aerosol Delivery Devices Tier 1, Tier 2, and Tier 3
5 Pulmonary Disease Aerosol Delivery Devices Market by Type
  1. 5.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Type
  2. 5.1.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pulmonary Disease Aerosol Delivery Devices Sales by Type
  6. 5.2.1 Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pulmonary Disease Aerosol Delivery Devices Price by Type
6 Pulmonary Disease Aerosol Delivery Devices Market by Application
  1. 6.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Application
  2. 6.1.1 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pulmonary Disease Aerosol Delivery Devices Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pulmonary Disease Aerosol Delivery Devices Sales by Application
  6. 6.2.1 Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pulmonary Disease Aerosol Delivery Devices Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pulmonary Disease Aerosol Delivery Devices Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Viatris
  14. 7.3.1 Viatris Company Information
  15. 7.3.2 Viatris Business Overview
  16. 7.3.3 Viatris Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Viatris Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  18. 7.3.5 Viatris Recent Developments
  19. 7.4 GlaxoSmithKline (GSK)
  20. 7.4.1 GlaxoSmithKline (GSK) Company Information
  21. 7.4.2 GlaxoSmithKline (GSK) Business Overview
  22. 7.4.3 GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline (GSK) Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  24. 7.4.5 GlaxoSmithKline (GSK) Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Vectura
  32. 7.6.1 Vectura Company Information
  33. 7.6.2 Vectura Business Overview
  34. 7.6.3 Vectura Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Vectura Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  36. 7.6.5 Vectura Recent Developments
  37. 7.7 Teva Pharmaceutical Industries
  38. 7.7.1 Teva Pharmaceutical Industries Company Information
  39. 7.7.2 Teva Pharmaceutical Industries Business Overview
  40. 7.7.3 Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Teva Pharmaceutical Industries Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  42. 7.7.5 Teva Pharmaceutical Industries Recent Developments
  43. 7.8 PARI International
  44. 7.8.1 PARI International Company Information
  45. 7.8.2 PARI International Business Overview
  46. 7.8.3 PARI International Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 PARI International Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  48. 7.8.5 PARI International Recent Developments
  49. 7.9 OMRON
  50. 7.9.1 OMRON Company Information
  51. 7.9.2 OMRON Business Overview
  52. 7.9.3 OMRON Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 OMRON Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  54. 7.9.5 OMRON Recent Developments
  55. 7.10 Monaghan Medical
  56. 7.10.1 Monaghan Medical Company Information
  57. 7.10.2 Monaghan Medical Business Overview
  58. 7.10.3 Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Monaghan Medical Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  60. 7.10.5 Monaghan Medical Recent Developments
  61. 7.11 Koninklijke Philips
  62. 7.11.1 Koninklijke Philips Company Information
  63. 7.11.2 Koninklijke Philips Business Overview
  64. 7.11.3 Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Koninklijke Philips Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  66. 7.11.5 Koninklijke Philips Recent Developments
  67. 7.12 H&T Presspart
  68. 7.12.1 H&T Presspart Company Information
  69. 7.12.2 H&T Presspart Business Overview
  70. 7.12.3 H&T Presspart Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 H&T Presspart Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  72. 7.12.5 H&T Presspart Recent Developments
  73. 7.13 Chiesi Farmaceutici
  74. 7.13.1 Chiesi Farmaceutici Company Information
  75. 7.13.2 Chiesi Farmaceutici Business Overview
  76. 7.13.3 Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Chiesi Farmaceutici Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  78. 7.13.5 Chiesi Farmaceutici Recent Developments
  79. 7.14 Boehringer Ingelheim
  80. 7.14.1 Boehringer Ingelheim Company Information
  81. 7.14.2 Boehringer Ingelheim Business Overview
  82. 7.14.3 Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Boehringer Ingelheim Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  84. 7.14.5 Boehringer Ingelheim Recent Developments
  85. 7.15 AptarGroup
  86. 7.15.1 AptarGroup Company Information
  87. 7.15.2 AptarGroup Business Overview
  88. 7.15.3 AptarGroup Pulmonary Disease Aerosol Delivery Devices Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 AptarGroup Pulmonary Disease Aerosol Delivery Devices Product Portfolio
  90. 7.15.5 AptarGroup Recent Developments
8 North America
  1. 8.1 North America Pulmonary Disease Aerosol Delivery Devices Market Size by Type
  2. 8.1.1 North America Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2032)
  3. 8.1.2 North America Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2032)
  4. 8.1.3 North America Pulmonary Disease Aerosol Delivery Devices Price by Type (2021-2032)
  5. 8.2 North America Pulmonary Disease Aerosol Delivery Devices Market Size by Application
  6. 8.2.1 North America Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2032)
  7. 8.2.2 North America Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2032)
  8. 8.2.3 North America Pulmonary Disease Aerosol Delivery Devices Price by Application (2021-2032)
  9. 8.3 North America Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  10. 8.3.1 North America Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pulmonary Disease Aerosol Delivery Devices Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pulmonary Disease Aerosol Delivery Devices Market Size by Type
  2. 9.1.1 Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2032)
  4. 9.1.3 Europe Pulmonary Disease Aerosol Delivery Devices Price by Type (2021-2032)
  5. 9.2 Europe Pulmonary Disease Aerosol Delivery Devices Market Size by Application
  6. 9.2.1 Europe Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2032)
  8. 9.2.3 Europe Pulmonary Disease Aerosol Delivery Devices Price by Application (2021-2032)
  9. 9.3 Europe Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  10. 9.3.1 Europe Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pulmonary Disease Aerosol Delivery Devices Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pulmonary Disease Aerosol Delivery Devices Market Size by Type
  2. 10.1.1 China Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2032)
  3. 10.1.2 China Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2032)
  4. 10.1.3 China Pulmonary Disease Aerosol Delivery Devices Price by Type (2021-2032)
  5. 10.2 China Pulmonary Disease Aerosol Delivery Devices Market Size by Application
  6. 10.2.1 China Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2032)
  7. 10.2.2 China Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2032)
  8. 10.2.3 China Pulmonary Disease Aerosol Delivery Devices Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pulmonary Disease Aerosol Delivery Devices Market Size by Type
  2. 11.1.1 Asia Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2032)
  4. 11.1.3 Asia Pulmonary Disease Aerosol Delivery Devices Price by Type (2021-2032)
  5. 11.2 Asia Pulmonary Disease Aerosol Delivery Devices Market Size by Application
  6. 11.2.1 Asia Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2032)
  8. 11.2.3 Asia Pulmonary Disease Aerosol Delivery Devices Price by Application (2021-2032)
  9. 11.3 Asia Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  10. 11.3.1 Asia Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pulmonary Disease Aerosol Delivery Devices Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pulmonary Disease Aerosol Delivery Devices Market Size by Type
  2. 12.1.1 SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pulmonary Disease Aerosol Delivery Devices Price by Type (2021-2032)
  5. 12.2 SAMEA Pulmonary Disease Aerosol Delivery Devices Market Size by Application
  6. 12.2.1 SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pulmonary Disease Aerosol Delivery Devices Price by Application (2021-2032)
  9. 12.3 SAMEA Pulmonary Disease Aerosol Delivery Devices Market Size by Country
  10. 12.3.1 SAMEA Pulmonary Disease Aerosol Delivery Devices Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pulmonary Disease Aerosol Delivery Devices Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pulmonary Disease Aerosol Delivery Devices Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pulmonary Disease Aerosol Delivery Devices Value Chain Analysis
  2. 13.1.1 Pulmonary Disease Aerosol Delivery Devices Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pulmonary Disease Aerosol Delivery Devices Production Mode & Process
  6. 13.2 Pulmonary Disease Aerosol Delivery Devices Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pulmonary Disease Aerosol Delivery Devices Distributors
  9. 13.2.3 Pulmonary Disease Aerosol Delivery Devices Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst